Barely Significant
← all excerpts

Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute.

Eur J Ophthalmol · 2021 · PMC8369912 · PMID 33673740

2
hedged sentences
closest p
boldest claim

The sentences

299 Another 2-year, double masked, placebo controlled parallel trial with 2% pirenzepine from the USA yielded a 41% reduction in myopia progression with 2% pirenzepine compared to the placebo treatment, however, the difference in axial elongation between the groups did not reach statistical significance. 300 As with atropine, the antimuscarinic properties of pirenzepine may lead to blurred near vision, sensitivity to light, some discomfort and itching, and medication residue on the eyelids or eyelashes.

also in 111,027 other papers

a clear trendno p-value reported
Based on a meta-analysis from 2015, there is a clear trend of higher myopia prevalence in the last 20 to 30 years across Western and Northern Europe. 89 , 91 In contrast, while the prevalence of myopia is reported to have been rising around the world, a similar trend in Southeast Norway appears to be absent. 58 Neither in Denmark, where nearly 140 years of

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.